FDA. Guidance For Industry. Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects.
I. INTRODUCTION
This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance.
This guidance provides an overview of the responsibilities of a person who conducts a clinical investigation of a drug, biological product, or medical device (an investigator as defined in 21 CFR 312.3(b) and 21 CFR 812.3(i)). The goal of this guidance is to help investigators better meet their responsibilities with respect to protecting human subjects and ensuring the integrity of the data from clinical investigations. This guidance is intended to clarify for investigators and sponsors FDA’s expectations concerning the investigator’s responsibility (1) to supervise a clinical study in which some study tasks are delegated to employees or colleagues of the investigator or other third parties and (2) to protect the rights, safety, and welfare of study subjects.
FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.
Authors:
Center for Drug Evaluation and Research
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research
OCTOBER 2009
Clinical Research News
今後の臨床試験
-
Intuitive Surgicalまだ募集していません
-
Bristol-Myers Squibbまだ募集していません
-
University of Alabama at Birminghamまだ募集していませんSpinal Cord Disordersアメリカ
-
Medical University of Viennaまだ募集していません血管アクセス | 血管アクセス合併症 | 透析カテーテル感染症 | 血液透析 | 血液透析合併症 | 透析アクセス機能障害 | ESRD (末期腎疾患) | 透析カテーテルオーストリア
-
NYU Langone HealthNational Cancer Institute (NCI)まだ募集していません
-
M.D. Anderson Cancer Centerまだ募集していません
-
Helwan Universityまだ募集していません
-
Prevention Strategies, LLCNational Institute on Drug Abuse (NIDA); NORC at the University of Chicagoまだ募集していませんアルコール関連障害 | タバコ使用障害 | マリファナの使用 | 物質関連障害
-
Second Affiliated Hospital of Nanchang UniversityBeijing Pearl Biotechnology Limited Liability Company募集
-
Ming Liuまだ募集していません
-
The First Affiliated Hospital of Soochow Universityまだ募集していません
-
Peking University First HospitalPeking University Shenzhen Hospitalまだ募集していません高齢患者 | がん手術 | 目標温度管理 | 低体温症、偶発的 | 神経認知回復の遅延中国
Clinical Research Jobs
-
United Kingdom - London
-
Germany - Hessen
-
United States - North Carolina - Durham
-
Poland - Krakow
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China
